|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 392.74 USD | -0.09% |
|
+7.20% | +19.89% |
| Jul. 28 | Barclays Adjusts Amgen Price Target to $360 From $350, Maintains Equalweight Rating | MT |
| Jul. 27 | Sarepta names former Abbvie president as CEO as Ingram retires | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 402.06 | 417.33 | 446.85 |
| Spread/Res. | -2.40% | -5.97% | -12.18% |
| Spread/Supp. | +7.75% | +10.46% | +20.26% |
| Support | 364.17 | 355.25 | 326.31 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
